OVERVIEW

New Vistas in Prostate Cancer Imaging is organized by Meetings By Mail, Global Education Group

Release date: May 1, 2022
Expiration date: April 30, 2025

Overview:
As the need to identify and treat prostate cancer increases, imaging is a critical tool in its diagnosis, staging and surveillance. This activity analyzes the two most promising imaging modalities for prostate cancer: multiparametric MRI and PSMA PET/CT. Essential concepts and multiple cases in both modalities are reviewed throughout the course, ensuring the audience a well rounded primer in the visualization and examination of this disease.

Learning Objectives:
After completing this activity, the participant should be better able to:

Describe state of the art mpMRI and molecular imaging techniques for detection, staging and surveillance of prostate cancer.
Discuss the utility of MRI fusion biopsy and in-bore biopsy in the detection of prostate cancer.
Develop a successful community based prostate imaging practice based on reliable high quality imaging with PIRADS Lexicon and multidisciplinary communication.
Describe novel theranostic therapies for the treatment of prostate cancer.
Review new molecular imaging acquisition and interpretation techniques for optimal prostate imaging.
Discuss the physiologic basis of PSMA therapy.
Discuss how radiogenomics will alter the future landscape of prostate cancer.

Topics:

PI-RADS
targeted biopsy
staging
controversies
Axumin
PET-C11 Choline
community challenges
plus more than 25 prostate cancer cases analyzing the use of mpMRI and PSMA PET/CT.